WHO: Coronavirus variant 1st detected in India is of global concern
The World Health Organization on Monday announced that B.1.617, the coronavirus variant first identified in India, is of global concern.
Maria Van Kerkhove, technical lead of WHO s coronavirus response, said that there is some available information to suggest some increased transmissibility of B.1.617, and more research is needed to determine whether COVID-19 vaccines are as effective against this variant. There are three other variants of global concern: the strains first detected in Britain, South Africa, and Brazil.
B.1.617 was first detected in India in October. The country is now experiencing a devastating COVID-19 outbreak, with hundreds of thousands of new cases reported every day. On Saturday, India recorded 4,187 deaths â the highest daily death toll since the start of the pandemic. Many believe that the actual number of new COVID-19 cases and deaths is much higher than what has been reported.
Sat, 08 May 2021 02:00 UTC
A new Vaccination Demand Observatory is using surveillance, bots, and behavior change mass marketing schemes to press reluctant people into getting the shots
The U.S. is awash in a surplus of coronavirus vaccines as there has been a sudden in drop in demand for them; most Americans who want the shots have had them. Now an army of Big Biotech s agencies set up to address vaccine hesitancy are turning up their mass marketing to create demand using surveillance, rapid data analysis, media control, and host of behavior control strategies they ve outlined in their playbooks.
Demand plummets
Print
California’s battle against coronavirus has progressed so rapidly in the last few months that many experts are optimistic the state has experienced the worst of the pandemic and that another disastrous wave is unlikely as vaccinations increase and case rates keep plunging.
If those forecasts hold fast, California will enter the summer in a better place than many thought. State officials hope to have the economy largely reopened by June 15. And while coronavirus variants caused concerns earlier this year, officials and experts say they have generally been less aggressive than feared and vaccines seem to be offering protection against the various variants.
5 things you need to know now - Kevin McCarthy tells House GOP to anticipate Cheney vote on Wednesday theweek.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theweek.com Daily Mail and Mail on Sunday newspapers.
https://www.afinalwarning.com/518123.html (Natural News) The U.S. is awash in a surplus of coronavirus vaccines as there has been a sudden in drop in demand for them; most Americans who want the shots have had them. Now an army of Big Biotech’s agencies set up to address “vaccine hesitancy” are turning up their mass marketing to “create demand” using surveillance, rapid data analysis, media control, and host of behavior control strategies they’ve outlined in their playbooks.
(Article by Celeste McGovern republished from LifeSiteNews.com)
Demand plummets
About 40% of the total adult population has been fully vaccinated, according to data from the Centers for Disease Control and Prevention (CDC). Uptake plummeted 25% after a peak in mid-April, and 56.4% of adults have had at least one dose of a coronavirus vaccine.